By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Sejal News NetworkSejal News NetworkSejal News Network
Notification Show More
Font ResizerAa
  • Latest News
  • Business
  • City News
  • Technology
  • Entertainment
  • Sports
  • Crime
  • Political
  • World
  • Biographies
Reading: Nureca Limited’s Manufacturing Subsidiary Secures US FDA Registration
Share
Font ResizerAa
Sejal News NetworkSejal News Network
  • Latest News
  • Business
  • City News
  • Technology
  • Entertainment
  • Sports
  • Crime
  • Political
  • World
  • Biographies
Search
  • Latest News
  • Business
  • City News
  • Technology
  • Entertainment
  • Sports
  • Crime
  • Political
  • World
  • Biographies
Have an existing account? Sign In
Follow US
Sejal News Network > News > Agency News > Nureca Limited’s Manufacturing Subsidiary Secures US FDA Registration
Agency NewsBusinessLatestPress Release

Nureca Limited’s Manufacturing Subsidiary Secures US FDA Registration

Sejal News Network Fav
Last updated: April 15, 2025 4:17 am
Sejal News Desk
Published: April 15, 2025
Share
SHARE

What is Nureca Limited’s Manufacturing Subsidiary Secures US FDA Registration?

Nureca Limited’s Manufacturing Subsidiary Secures US FDA Registration is a trending topic covered by Sejal News Network with latest updates and insights.

Contents
What is Nureca Limited’s Manufacturing Subsidiary Secures US FDA Registration?Related News

Nureca Technologies Private Limited, the manufacturing subsidiary of Nureca Limited, has successfully completed its annual registration with the United States Food and Drug Administration (US FDA). The company’s manufacturing facility in Mohali, Punjab is now officially listed under Registration Number: 3036779619.

This registration authorizes Nureca Technologies to continue manufacturing and exporting a suite of medical devices to the United States-reinforcing the company’s commitment to quality, regulatory compliance, and global expansion.

The following products have been listed with the US FDA:

  • Pad, Heating, Powered – Dr Trust

  • Bed, Flotation Therapy, Powered – Dr Trust

  • Stethoscope, Manual – Dr Trust

  • Massager, Therapeutic, Electric – Dr Physio; Dr Trust

  • Pump, Breast, Non-Powered – Dr Trust; Trumom

These medical devices are 510(k) exempt, classified as low-to-moderate risk by the FDA, and comply with all applicable quality system regulations and labeling requirements for the U.S. market.

In addition to these listed products, the Mohali facility also manufactures a diverse portfolio of consumer-focused healthcare devices, including blood pressure monitors, nebulizers, electric massagers, oral and infrared thermometers, heating pads, orthopedic cushions and pillows, breast pumps, footcare products, and vaporizers. The facility is already approved by the Central Drugs Standard Control Organisation (CDSCO) and is certified for ISO 9001:2015 and ISO 13485:2016 by Intertek, underscoring Nureca’s adherence to global quality management and medical device manufacturing standards.

Mr. Saurabh Goyal, Chairman and Managing Director of Nureca Limited, commented, “Securing FDA registration is a significant milestone in our global journey. It reinforces Nureca’s core mission to manufacture trusted, innovative, and regulation-compliant healthcare products for consumers around the world.”

Nureca Technologies plays a pivotal role in the design and manufacturing of smart, accessible, and consumer-focused devices under Nureca’s flagship brands – Dr Trust, Dr Physio, and Trumom.

About Nureca Limited
Nureca Limited is a leading home healthcare and wellness company with a digital-first approach. Through its innovative product lines, Nureca empowers individuals to take charge of their health with clinically validated, easy-to-use devices that support preventive care and wellness.

(The above press release has been provided by NewsVoir.)

Read More:
Navi Mumbai News | Business News India | Entertainment News

Related News

  • Opalus Series Lever Handles by Hafele
  • Gut Microbiota Diets Boost Effectiveness of Anti-Diabetic Medications, Study Finds
  • Mulson Reatil's Website Faces Technical Challenges Shortly After Launch
Share This Article
Facebook Email Print

Follow US

Find US on Social Medias
FacebookLike
XFollow
InstagramFollow
Popular News
Press Release

Recognizing Excellence: Chitkara University Bestows Honorary Doctorate on Dr. Arvind Lal for Healthcare Innovation

May 24, 2024
Amazon and IIT-Bombay work together on AI-ML projects.
Cellex Battery Systems Powers Ahead with Successful Conclusion of its Third Funding Round
Grant Thornton Bharat Acts as Exclusive Advisor to Biorad Medisys for its Fundraise of up to INR 400 Crore from Kotak Strategic Situations India Fund II
Vijay Jain, Managing Director of Star Estate Bags Prestigious Times Power Icon 2024 Award

About US

Sejal News Network is an independent digital news platform delivering breaking news, city updates, entertainment, box office reports, politics, technology and public interest stories with accuracy and transparency. contact@sejalnewsnetwork.in
Quick Links
  • About
  • Disclaimer
  • Terms & Conditions
  • Contact
  • Staff Directory
  • Privacy Policy
  • Corrections Policy
  • Editorial Policy
  • Fact-Checking Policy
  • Ownership & Funding
  • Sitemap
  • Rss Feed
Categories
  • Latest News
  • Business
  • City News
  • Technology
  • Entertainment
  • Sports
  • Crime
  • Political
  • World
  • Biographies
© Sejal News Network. Sejal Media And Network. All Rights Reserved.
  • 📱 ॲप
  • 📰 ताज्या बातम्या
  • 🎥डिजिटल कलाकार
  • 📖 वेब स्टोरी
Go to mobile version
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?